H

Helex Bio

22 employees

Enabling Safer Gene Editing

Basic info

Industry

biotechnology research

Sectors

Biotechnology
CRO
Molecular Biology
De Novo Genome Assembly
Genomics
gRNA
Variant Analysis
epigenetics
rare diseases
Post experimental analysis
Genetics
Sequencing
Bioinformatics
AI/ ML
gRNA design
CRISPR
genetic medicines drug design
cell specific editing
Sanger Sequencing
gene editing
3D spatial structures
CRISPR Analyisis
bioinformatics
multi-omics
Custom Analysis Pipeline
NGS

Date founded

2021

Funding rounds raised

Total raised

$1.1M

from 6 investors over 6 rounds

H

Helex Bio raised undisclosed on October 17, 2022

Investors: IndieBio and SOSV - The Accelerator VC

H

Helex Bio raised $1.1M on August 31, 2021

Investors: IndieBio and SOSV - The Accelerator VC

H

Helex Bio raised undisclosed on August 31, 2021

Investors: IndieBio and SOSV - The Accelerator VC

FAQ